GlassScriptPhysician profile
Ryan Salvador
NPI 1649582883
$1,739.18
in general payments reported to CMS, 2019-2025
20 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $278 · 2021: $103 · 2022: $429 · 2023: $90.42 · 2024: $179 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $622.28 | 2019-2024 | Ruconest |
| Genzyme Corporation | $179.86 | 2024-2025 | |
| Becton, Dickinson and Company | $151.28 | 2019 | |
| Csl Behring | $123.75 | 2019-2021 | |
| Glaxosmithkline, LLC. | $107.12 | 2022-2025 | Nucala |
| Qiagen, LLC | $75.82 | 2025 | |
| Smith+Nephew, INC. | $55.82 | 2021-2025 | Tula |
| Takeda Pharmaceuticals U.S.A., INC. | $53.72 | 2020 | |
| Aerin Medical INC. | $51.31 | 2020 | |
| Stryker Corporation | $49.71 | 2021 | |
| Integra Lifesciences Corporation | $41.61 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Phadia US INC. | $34.22 | 2019-2023 | Immunocap |
| Regeneron Healthcare Solutions, INC. | $33.88 | 2025 | Dupixent |
| Shire North American Group INC | $28.33 | 2019 | |
| Intersect Ent, INC. | $27.44 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.82 | 2023 | |
| Kerecis Limited | $23.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Itamar Medical INC | $22.93 | 2024 | Watchpatone |
| Neurent Medical Limited | $17.15 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Medtronic, INC. | $13.75 | 2024 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Salvador listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.